These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9204059)

  • 1. High-dose UVA1 radiation therapy for localized scleroderma.
    Stege H; Berneburg M; Humke S; Klammer M; Grewe M; Grether-Beck S; Boedeker R; Diepgen T; Dierks K; Goerz G; Ruzicka T; Krutmann J
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):938-44. PubMed ID: 9204059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose UVA phototherapy for treatment of localized scleroderma.
    Kerscher M; Volkenandt M; Gruss C; Reuther T; von Kobyletzki G; Freitag M; Dirschka T; Altmeyer P
    J Am Acad Dermatol; 1998 Jan; 38(1):21-6. PubMed ID: 9448200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma.
    Su O; Onsun N; Onay HK; Erdemoglu Y; Ozkaya DB; Cebeci F; Somay A
    Int J Dermatol; 2011 Aug; 50(8):1006-13. PubMed ID: 21781079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment.
    Sator PG; Radakovic S; Schulmeister K; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2009 May; 60(5):786-91. PubMed ID: 19211170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
    Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of a new ultraviolet A
    Arndt S; Lissner C; Unger P; Bäumler W; Berneburg M; Karrer S
    Exp Dermatol; 2020 Dec; 29(12):1199-1208. PubMed ID: 32592187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
    Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
    Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
    Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
    J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
    Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
    J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of light emitting diodes-based ultraviolet A1 phototherapy in bleomycin-induced scleroderma in mice.
    Karpec D; Rudys R; Leonaviciene L; Mackiewicz Z; Bradunaite R; Kirdaite G; Venalis A
    Adv Med Sci; 2018 Mar; 63(1):152-159. PubMed ID: 29120857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of high-dose narrowband ultraviolet A1 on dermal thickness, collagen and matrix-metalloproteinases in animal model of scleroderma.
    Karpec D; Rudys R; Leonaviciene L; Mackiewicz Z; Bradunaite R; Kirdaite G; Venalis A
    J Photochem Photobiol B; 2017 Aug; 173():448-455. PubMed ID: 28667931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
    Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
    J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method.
    de Rie MA; Enomoto DN; de Vries HJ; Bos JD
    Dermatology; 2003; 207(3):298-301. PubMed ID: 14571073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet A1 phototherapy for the treatment of localized scleroderma.
    Furuhashi T; Torii K; Ikumi K; Kato H; Nishida E; Morita A
    J Dermatol; 2020 Jul; 47(7):792-795. PubMed ID: 32383187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose UVA1 radiation therapy for localized scleroderma.
    Su RC; Chong LY; Lo KK
    J Am Acad Dermatol; 1998 Sep; 39(3):517-8. PubMed ID: 9738800
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose ultraviolet A1 (UVA1) phototherapy: does it work?
    Krutmann J
    Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):78-81. PubMed ID: 9372519
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis.
    Kreuter A; Breuckmann F; Uhle A; Brockmeyer N; Von Kobyletzki G; Freitag M; Stuecker M; Hoffmann K; Gambichler T; Altmeyer P
    J Am Acad Dermatol; 2004 May; 50(5):740-7. PubMed ID: 15097958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose broad-band UVA in morphea using a new method for evaluation.
    El-Mofty M; Zaher H; Bosseila M; Yousef R; Saad B
    Photodermatol Photoimmunol Photomed; 2000 Apr; 16(2):43-9. PubMed ID: 10823310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts.
    Gruss C; Reed JA; Altmeyer P; McNutt NS; Kerscher M
    Lancet; 1997 Nov; 350(9087):1295-6. PubMed ID: 9357412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.